U. Bruntsch

A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck

G. Catimel, Jan B. Vermorken, M. Clavel et al. · Annals of Oncology · 1994 · 135 citations

Medicine, Ly 188011, Phase Ii Study +8

The EORTC early clinical trials cooperative group experience with 5-aza-2′-deoxycytidine (NSC 127716) in patients with colo-rectal, head and neck, renal carcinomas and malignant melanomas

R Abele, M. Clavel, P. Dodion et al. · European Journal of Cancer and Clinical Oncology · 1987 · 118 citations

Malignant Melanomas, Radiation Medicine, Medicine +11

Phase I and pharmacokinetic study of CCI-779, a novel cytostatic cell-cycle inhibitor, in combination with 5-fluorouracil and leucovorin in patients with advanced solid tumors

Cornelis J.A. Punt, Joseph Boni, U. Bruntsch et al. · Annals of Oncology · 2003 · 117 citations · Full text

Does dexamethasone enhance control of acute cisplatin induced emesis by ondansetron?

John F. Smyth, Robert E. Coleman, Malcolm Nicolson et al. · BMJ · 1991 · 105 citations · Full text

Moderate Dose Escalation for Advanced Stage Hodgkin’s Disease Using the Bleomycin, Etoposide, Adriamycin, Cyclophosphamide, Vincristine, Procarbazine, and Prednisone Scheme and Adjuvant Radiotherapy: A Study of the German Hodgkin’s Lymphoma Study Group

Hans Tesch, Volker Diehl, B. Lathan et al. · Blood · 1998 · 72 citations